Physician profile
Michael V Como
NPI 1497727796
$27,266.89
in general payments reported to CMS, 2019-2025
44 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,620 · 2020: $1,468 · 2021: $3,015 · 2022: $2,694 · 2023: $2,983 · 2024: $3,427 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $5,580 · Travel and Lodging: $885 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,566.76 |
| Consulting Fee | $5,580.00 |
| Travel and Lodging | $885.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Education | $137.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $9,732.74 | 2019-2025 | Breztri, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $4,275.75 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,844.48 | 2019-2025 | Ofev, Jardiance, Stiolto Respimat |
| United Therapeutics Corporation | $1,155.39 | 2021-2025 | Tyvaso, Tyvaso |
| Atricure, INC. | $1,127.53 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Actelion Pharmaceuticals US, INC. | $1,077.12 | 2020-2025 | Opsumit, Uptravi |
| Philips North America LLC | $868.23 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Genzyme Corporation | $867.86 | 2019-2025 | |
| Baxter Healthcare | $493.87 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 205 Acute Care |
| Genentech USA, INC. | $474.81 | 2019-2025 | Xolair |
| Insmed, INC. | $436.27 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $433.56 | 2021-2025 | Tezspire, Tavneos |
| Mylan Specialty L.P. | $426.69 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $403.03 | 2022-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $355.13 | 2019-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $330.48 | 2021-2025 | Acthar |
| Sunovion Pharmaceuticals INC. | $327.86 | 2019-2020 | |
| Electromed, INC. | $251.41 | 2021-2025 | Smartvest |
| Advanced Respiratory, INC | $218.93 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $217.16 | 2020-2022 | |
| Grifols USA, LLC | $202.13 | 2020-2024 | Prolastin-C Liquid |
| Verona Pharma, INC. | $193.92 | 2025 | Ohtuvayre |
| Cvrx, INC. | $163.59 | 2025 | Barostim Neo System |
| Viatris Specialty LLC | $150.58 | 2025 | Yupelri |
| Abbott Laboratories | $143.57 | 2025 | Assurity |
| Olympus America INC. | $125.00 | 2022 | |
| Pulmonx Corporation | $124.99 | 2019 | |
| Merck Sharp & Dohme LLC | $111.85 | 2019-2025 | Capvaxive, Winrevair |
| Vifor Pharma, INC. | $106.55 | 2024-2025 | Zemaira |
| Medtronic, INC. | $70.30 | 2025 | Linq II |
| Shionogi INC | $67.04 | 2022-2024 | Fetroja |
| Mallinckrodt Enterprises LLC | $64.50 | 2019 | |
| Inspire Medical Systems, INC. | $62.90 | 2025 | Inspire |
| Astellas Pharma US INC | $60.84 | 2024 | Veozah |
| Gilead Sciences, INC. | $53.12 | 2021-2025 | Veklury |
| Inogen, INC. | $47.26 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Takeda Pharmaceuticals U.S.A., INC. | $46.87 | 2020-2024 | Glassia |
| Circassia INC. | $38.96 | 2019 | |
| La Jolla Pharmaceutical Company | $31.87 | 2019 | |
| Inari Medical, INC. | $20.49 | 2020 | |
| Pfizer INC. | $19.52 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.92 | 2023 | Ultomiris |
| Shire North American Group INC | $14.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Como listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.